Valerie Mandriota Banner-Goodspeed, M.P.H.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Insufficiency | 7 | 2023 | 1213 | 0.780 |
Why?
|
Respiration, Artificial | 9 | 2023 | 2573 | 0.520 |
Why?
|
Cardiac Surgical Procedures | 7 | 2022 | 3543 | 0.430 |
Why?
|
Propofol | 4 | 2022 | 605 | 0.410 |
Why?
|
Delirium | 5 | 2022 | 1637 | 0.390 |
Why?
|
Survivors | 7 | 2023 | 2303 | 0.360 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 119 | 0.360 |
Why?
|
Critical Illness | 7 | 2022 | 2691 | 0.340 |
Why?
|
Hospital Mortality | 7 | 2022 | 5218 | 0.320 |
Why?
|
Anesthesia, Conduction | 2 | 2022 | 230 | 0.310 |
Why?
|
Positive-Pressure Respiration | 3 | 2021 | 628 | 0.300 |
Why?
|
Patient Discharge | 5 | 2023 | 3316 | 0.290 |
Why?
|
Intensive Care Units | 10 | 2023 | 3674 | 0.280 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2021 | 388 | 0.270 |
Why?
|
Lung Injury | 2 | 2022 | 432 | 0.260 |
Why?
|
Anesthetics, Inhalation | 2 | 2022 | 568 | 0.260 |
Why?
|
Heme | 2 | 2023 | 301 | 0.220 |
Why?
|
Neuromuscular Blockade | 2 | 2021 | 147 | 0.210 |
Why?
|
Survival | 1 | 2021 | 159 | 0.190 |
Why?
|
Methyl Ethers | 1 | 2022 | 195 | 0.180 |
Why?
|
Neutrophils | 2 | 2023 | 3709 | 0.180 |
Why?
|
Esophagus | 3 | 2021 | 1014 | 0.180 |
Why?
|
Oxygen | 3 | 2021 | 4188 | 0.170 |
Why?
|
Embolism, Paradoxical | 1 | 2019 | 54 | 0.160 |
Why?
|
Relaxation Therapy | 1 | 2019 | 176 | 0.160 |
Why?
|
Enoxaparin | 1 | 2021 | 382 | 0.160 |
Why?
|
Acetaminophen | 2 | 2021 | 539 | 0.160 |
Why?
|
Hypnotics and Sedatives | 3 | 2022 | 1163 | 0.150 |
Why?
|
Hospitalization | 6 | 2023 | 10342 | 0.150 |
Why?
|
Dissent and Disputes | 1 | 2019 | 146 | 0.150 |
Why?
|
Critical Care | 3 | 2023 | 2660 | 0.150 |
Why?
|
Intraoperative Complications | 1 | 2024 | 1178 | 0.140 |
Why?
|
Registries | 3 | 2022 | 8176 | 0.140 |
Why?
|
Intraoperative Care | 1 | 2021 | 748 | 0.140 |
Why?
|
Thrombosis | 2 | 2021 | 3000 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2019 | 244 | 0.140 |
Why?
|
Hypothyroidism | 1 | 2022 | 662 | 0.140 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 377 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 421 | 0.140 |
Why?
|
Respiration | 1 | 2023 | 1644 | 0.140 |
Why?
|
Virus Diseases | 1 | 2022 | 724 | 0.140 |
Why?
|
Foramen Ovale, Patent | 1 | 2019 | 212 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 2 | 2019 | 1063 | 0.130 |
Why?
|
Postoperative Complications | 4 | 2024 | 15366 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 972 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 360 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1151 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 2017 | 346 | 0.130 |
Why?
|
Hyperoxia | 1 | 2017 | 261 | 0.130 |
Why?
|
Quality of Life | 5 | 2023 | 12980 | 0.120 |
Why?
|
Professional-Family Relations | 1 | 2019 | 488 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 538 | 0.120 |
Why?
|
Dexmedetomidine | 1 | 2019 | 313 | 0.120 |
Why?
|
Heparin | 1 | 2021 | 1631 | 0.110 |
Why?
|
Nurses | 1 | 2023 | 2441 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1398 | 0.110 |
Why?
|
Cognition | 3 | 2020 | 6786 | 0.110 |
Why?
|
Adult | 25 | 2024 | 215291 | 0.110 |
Why?
|
Aged | 22 | 2024 | 164472 | 0.100 |
Why?
|
Humans | 49 | 2024 | 746897 | 0.100 |
Why?
|
Length of Stay | 6 | 2023 | 6299 | 0.100 |
Why?
|
Perioperative Care | 1 | 2020 | 1004 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 892 | 0.100 |
Why?
|
Vitamins | 1 | 2019 | 1611 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 933 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2021 | 2190 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 10096 | 0.090 |
Why?
|
Double-Blind Method | 6 | 2021 | 12231 | 0.090 |
Why?
|
Middle Aged | 22 | 2024 | 214711 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2115 | 0.090 |
Why?
|
Terminal Care | 1 | 2022 | 1726 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2517 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1355 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1846 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2019 | 1251 | 0.090 |
Why?
|
Prospective Studies | 10 | 2023 | 53276 | 0.090 |
Why?
|
Hemorrhage | 1 | 2021 | 3523 | 0.080 |
Why?
|
Male | 26 | 2024 | 351556 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2410 | 0.080 |
Why?
|
Aspirin | 2 | 2022 | 3288 | 0.080 |
Why?
|
Cohort Studies | 8 | 2024 | 40540 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2250 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1867 | 0.080 |
Why?
|
Anesthetics, Intravenous | 2 | 2022 | 397 | 0.080 |
Why?
|
Pandemics | 3 | 2022 | 8445 | 0.070 |
Why?
|
Female | 25 | 2024 | 382617 | 0.070 |
Why?
|
Boston | 4 | 2021 | 9213 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2244 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4022 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1678 | 0.060 |
Why?
|
Anticoagulants | 1 | 2021 | 4734 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3227 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3071 | 0.060 |
Why?
|
Anxiety | 1 | 2019 | 4408 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3835 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4537 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9128 | 0.060 |
Why?
|
Treatment Failure | 2 | 2020 | 2616 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6465 | 0.060 |
Why?
|
Rwanda | 2 | 2016 | 650 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15562 | 0.060 |
Why?
|
Motivation | 2 | 2023 | 1964 | 0.050 |
Why?
|
Immersion | 1 | 2022 | 35 | 0.050 |
Why?
|
Toll-Like Receptor 9 | 1 | 2023 | 232 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2024 | 78361 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 205 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57627 | 0.050 |
Why?
|
Neostigmine | 1 | 2020 | 66 | 0.050 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2135 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1428 | 0.040 |
Why?
|
Risk Factors | 7 | 2022 | 72453 | 0.040 |
Why?
|
Tidal Volume | 1 | 2022 | 482 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 192 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2022 | 264 | 0.040 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 1396 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 302 | 0.040 |
Why?
|
Sex Factors | 2 | 2024 | 10287 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2021 | 63767 | 0.040 |
Why?
|
Time | 1 | 2021 | 540 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 239 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2020 | 5096 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3859 | 0.040 |
Why?
|
Patient Positioning | 1 | 2021 | 323 | 0.040 |
Why?
|
Chemokines | 1 | 2022 | 963 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 186 | 0.040 |
Why?
|
Patient Readmission | 2 | 2023 | 3177 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 835 | 0.040 |
Why?
|
Partial Pressure | 1 | 2017 | 245 | 0.040 |
Why?
|
Oximetry | 1 | 2021 | 461 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 254 | 0.040 |
Why?
|
Comorbidity | 2 | 2022 | 10378 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 641 | 0.040 |
Why?
|
Hand | 1 | 2022 | 877 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2021 | 957 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2026 | 0.030 |
Why?
|
Stroke | 1 | 2019 | 9693 | 0.030 |
Why?
|
Time Factors | 4 | 2020 | 39639 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1850 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2022 | 2920 | 0.030 |
Why?
|
Age Distribution | 1 | 2022 | 2839 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1150 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14126 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1824 | 0.030 |
Why?
|
Actins | 1 | 2023 | 2058 | 0.030 |
Why?
|
Social Perception | 1 | 2019 | 424 | 0.030 |
Why?
|
Lung | 3 | 2022 | 9914 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 415 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1138 | 0.030 |
Why?
|
Mental Recall | 1 | 2021 | 1196 | 0.030 |
Why?
|
United States | 5 | 2023 | 70460 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3677 | 0.030 |
Why?
|
Incidence | 3 | 2019 | 20822 | 0.030 |
Why?
|
Hospitals, Public | 1 | 2016 | 194 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2014 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2017 | 1146 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2824 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2385 | 0.030 |
Why?
|
Age Factors | 2 | 2022 | 18160 | 0.030 |
Why?
|
Operating Rooms | 1 | 2019 | 777 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1369 | 0.030 |
Why?
|
Anesthesia | 1 | 2024 | 1558 | 0.030 |
Why?
|
Research Design | 2 | 2019 | 6066 | 0.030 |
Why?
|
Social Support | 1 | 2022 | 2118 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1113 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21702 | 0.030 |
Why?
|
Postoperative Care | 1 | 2019 | 1467 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1658 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2119 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1630 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4321 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2843 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25197 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2021 | 2716 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2925 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2470 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4343 | 0.020 |
Why?
|
Attitude to Health | 1 | 2019 | 2028 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 38812 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2676 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9600 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 86323 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 57221 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6463 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3416 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2708 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4285 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3239 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5255 | 0.020 |
Why?
|
Mice | 2 | 2023 | 80291 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7941 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 3087 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 6950 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12659 | 0.020 |
Why?
|
Poverty | 1 | 2016 | 2616 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9522 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7281 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3741 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14546 | 0.010 |
Why?
|
Developing Countries | 1 | 2016 | 2803 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5903 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5259 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5038 | 0.010 |
Why?
|
Animals | 2 | 2023 | 166593 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12724 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41406 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19827 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7706 | 0.010 |
Why?
|
Child | 1 | 2022 | 78517 | 0.010 |
Why?
|